Periocream Set to Revolutionize Dental Treatments

Bonyf NV is preparing to launch Periocream, a new dental treatment aimed exclusively at dental professionals. Expected to soon receive a final report confirming market readiness, this innovative product is protected by a European patent, with a U.S. patent pending. Periocream's NitrAdine®-based formula is designed to disrupt biofilm formation, improving healing and patient comfort based on trials with 30 patients.

The company is finalizing regulatory processes to achieve Class IIa Medical Device status in Europe and anticipates FDA approval in about five months. Distributor interest is strong, with partnerships forming in Europe, the U.S., and Japan. Bonyf projects a Q4 2025 commercial launch in Europe, U.S. market entry by Q1 2026, and expansion into Japan later.